Longieva Therapeutics, Inc.

San Jose, CA Longieva Therapeutics

UEI
E2ZQPH9HA147
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
200 Jose Figueres Ave Ste 390, San Jose, CA 95116, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Longieva Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of cannabinoid receptor 2 agonists for opioid use disorder - project summary substance use disorders… Grant · R43DA066396 National Institute on Drug Abuse $399,989

Quick answers

What is Longieva Therapeutics, Inc.'s UEI?

Longieva Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is E2ZQPH9HA147.

Where is Longieva Therapeutics, Inc. located?

Longieva Therapeutics, Inc.'s physical address in SAM.gov is 200 Jose Figueres Ave Ste 390, San Jose, CA 95116, USA.

Is Longieva Therapeutics, Inc. registered in SAM.gov?

Yes. Longieva Therapeutics, Inc.'s SAM.gov registration is active through August 26, 2027.

What is Longieva Therapeutics, Inc.'s most recent federal award?

Longieva Therapeutics, Inc.'s most recent federal grant award is Development of cannabinoid receptor 2 agonists for opioid use disorder - project summary substance use disorders… (R43DA066396), from National Institute on Drug Abuse, on August 15, 2026.

On GovTribe

See Longieva Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login